List of Tables
Summary Table: Global Market for Drug Discovery Technologies, by Technology, Through 2029
Table 1: Porter’s Five Forces Analysis of the Drug Discovery Technologies Market
Table 2: Global Diabetes Prevalence, Estimates and Projections, 2021-2045
Table 3: Global Prevalence of Multiple Sclerosis, by WHO Region, 2013 and 2020
Table 4: Global HIV Epidemic, by Age Group, 2023
Table 5: Global Population Growth, by Age Group, Through 2050
Table 6: Global Market for Drug Discovery Technologies, by Technology, Through 2029
Table 7: Global Market for HTS in Drug Discovery, by Region, Through 2029
Table 8: Global Market for Bioanalytical Instruments in Drug Discovery, by Product Type, Through 2029
Table 9: Global Market for Bioanalytical Instruments in Drug Discovery, by Region, Through 2029
Table 10: Global Market for Genomics in Drug Discovery, by Product Type, Through 2029
Table 11: Global Market for Genomics in Drug Discovery, by Region, Through 2029
Table 12: Protein Microarrays and Their Functions
Table 13: Global Market for Proteomics in Drug Discovery, by Product Type, Through 2029
Table 14: Global Market for Proteomics in Drug Discovery, by Region, Through 2029
Table 15: Cell Biology Reagents and Their Functions
Table 16: Global Market for Cell-Based Assays and Reagents in Drug Discovery, by Product Type, Through 2029
Table 17: Global Market for Cell-based Assays and Reagents in Drug Discovery, by Region, Through 2029
Table 18: Global Market for Bioinformatics in Drug Discovery, by Region, Through 2029
Table 19: Comparison of Solid-Phase and Solution-Phase Synthesis
Table 20: Global Market for Other Technologies in Drug Discovery, by Region, Through 2029
Table 21: Global Market for Drug Discovery Technologies, by Application, Through 2029
Table 22: Global Market for Drug Discovery Technologies in Oncology, by Region, Through 2029
Table 23: Global Market for Drug Discovery Technologies in Cardiology, by Region, Through 2029
Table 24: Global Market for Drug Discovery Technologies in Neurodegenerative Diseases, by Region, Through 2029
Table 25: Global Market for Drug Discovery Technologies in Immunological Diseases, by Region, Through 2029
Table 26: Global Market for Drug Discovery Technologies in Other Diseases, by Region, Through 2029
Table 27: Global Market for Drug Discovery Technologies, by End User, Through 2029
Table 28: Global Market for Drug Discovery Technologies in Biopharma Companies, by Region, Through 2029
Table 29: Global Market for Drug Discovery Technologies in Research and Academia, by Region, Through 2029
Table 30: Global Market for Drug Discovery Technologies in CROs, by Region, Through 2029
Table 31: Global Market for Drug Discovery Technologies, by Region, Through 2029
Table 32: North American Market for Drug Discovery Technologies, by Technology, Through 2029
Table 33: North American Market for Drug Discovery Technologies, by Application, Through 2029
Table 34: North American Market for Drug Discovery Technologies, by End User, Through 2029
Table 35: North American Market for Drug Discovery Technologies, by Country, Through 2029
Table 36: U.S. Market for Drug Discovery Technologies, by Technology, Through 2029
Table 37: U.S. Market for Drug Discovery Technologies, by Application, Through 2029
Table 38: U.S. Market for Drug Discovery Technologies, by End User, Through 2029
Table 39: Canadian Market for Drug Discovery Technologies, by Technology, Through 2029
Table 40: Canadian Market for Drug Discovery Technologies, by Application, Through 2029
Table 41: Canadian Market for Drug Discovery Technologies, by End User, Through 2029
Table 42: Mexican Market for Drug Discovery Technologies, by Technology, Through 2029
Table 43: Mexican Market for Drug Discovery Technologies, by Application, Through 2029
Table 44: Mexican Market for Drug Discovery Technologies, by End User, Through 2029
Table 45: European Market for Drug Discovery Technologies, by Technology, Through 2029
Table 46: European Market for Drug Discovery Technologies, by Application, Through 2029
Table 47: European Market for Drug Discovery Technologies, by End User, Through 2029
Table 48: European Market for Drug Discovery Technologies, by Country, Through 2029
Table 49: German Market for Drug Discovery Technologies, by Technology, Through 2029
Table 50: German Market for Drug Discovery Technologies, by Application, Through 2029
Table 51: German Market for Drug Discovery Technologies, by End User, Through 2029
Table 52: U.K. Market for Drug Discovery Technologies, by Technology, Through 2029
Table 53: U.K. Market for Drug Discovery Technologies, by Application, Through 2029
Table 54: U.K. Market for Drug Discovery Technologies, by End User, Through 2029
Table 55: French Market for Drug Discovery Technologies, by Technology, Through 2029
Table 56: French Market for Drug Discovery Technologies, by Application, Through 2029
Table 57: French Market for Drug Discovery Technologies, by End User, Through 2029
Table 58: Italian Market for Drug Discovery Technologies, by Technology, Through 2029
Table 59: Italian Market for Drug Discovery Technologies, by Application, Through 2029
Table 60: Italian Market for Drug Discovery Technologies, by End User, Through 2029
Table 61: Spanish Market for Drug Discovery Technologies, by Technology, Through 2029
Table 62: Spanish Market for Drug Discovery Technologies, by Application, Through 2029
Table 63: Spanish Market for Drug Discovery Technologies, by End User, Through 2029
Table 64: Rest of Europe Market for Drug Discovery Technologies, by Technology, Through 2029
Table 65: Rest of Europe Market for Drug Discovery Technologies, by Application, Through 2029
Table 66: Rest of Europe Market for Drug Discovery Technologies, by End User, Through 2029
Table 67: Asia-Pacific Market for Drug Discovery Technologies, by Technology, Through 2029
Table 68: Asia-Pacific Market for Drug Discovery Technologies, by Application, Through 2029
Table 69: Asia-Pacific Market for Drug Discovery Technologies, by End User, Through 2029
Table 70: Asia-Pacific Market for Drug Discovery Technologies, by Country, Through 2029
Table 71: Chinese Market for Drug Discovery Technologies, by Technology, Through 2029
Table 72: Chinese Market for Drug Discovery Technologies, by Application, Through 2029
Table 73: Chinese Market for Drug Discovery Technologies, by End User, Through 2029
Table 74: Japanese Market for Drug Discovery Technologies, by Technology, Through 2029
Table 75: Japanese Market for Drug Discovery Technologies, by Application, Through 2029
Table 76: Japanese Market for Drug Discovery Technologies, by End User, Through 2029
Table 77: Indian Market for Drug Discovery Technologies, by Technology, Through 2029
Table 78: Indian Market for Drug Discovery Technologies, by Application, Through 2029
Table 79: Indian Market for Drug Discovery Technologies, by End User, Through 2029
Table 80: South Korean Market for Drug Discovery Technologies, by Technology, Through 2029
Table 81: South Korean Market for Drug Discovery Technologies, by Application, Through 2029
Table 82: South Korean Market for Drug Discovery Technologies, by End User, Through 2029
Table 83: Australian Market for Drug Discovery Technologies, by Technology, Through 2029
Table 84: Australian Market for Drug Discovery Technologies, by Application, Through 2029
Table 85: Australian Market for Drug Discovery Technologies, by End User, Through 2029
Table 86: Rest of Asia-Pacific Market for Drug Discovery Technologies, by Technology, Through 2029
Table 87: Rest of Asia-Pacific Market for Drug Discovery Technologies, by Application, Through 2029
Table 88: Rest of Asia-Pacific Market for Drug Discovery Technologies, by End User, Through 2029
Table 89: RoW Market for Drug Discovery Technologies, by Technology, Through 2029
Table 90: RoW Market for Drug Discovery Technologies, by Application, Through 2029
Table 91: RoW Market for Drug Discovery Technologies, by End User, Through 2029
Table 92: RoW Market for Drug Discovery Technologies, by Sub-Region, Through 2029
Table 93: South American Market for Drug Discovery Technologies, by Technology, Through 2029
Table 94: South American Market for Drug Discovery Technologies, by Application, Through 2029
Table 95: South American Market for Drug Discovery Technologies, by End User, Through 2029
Table 96: MEA Market for Drug Discovery Technologies, by Technology, Through 2029
Table 97: MEA Market for Drug Discovery Technologies, by Application, Through 2029
Table 98: MEA Market for Drug Discovery Technologies, by End User, Through 2029
Table 99: Focus Areas in ESG Metrics
Table 100: ESG Rankings for Drug Discovery Technologies, as of May 2024
Table 101: Abbreviations Used in this Report
Table 102: Report Sources
Table 103: Agilent Technologies Inc.: Company Snapshot
Table 104: Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
Table 105: Agilent Technologies Inc.: Product Portfolio
Table 106: Agilent Technologies Inc.: News/Key Development, 2024
Table 107: Bio-Rad Laboratories Inc.: Company Snapshot
Table 108: Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 109: Bio-Rad Laboratories Inc.: Product Portfolio
Table 110: Bio-Rad Laboratories Inc.: News/Key Developments, 2024
Table 111: Bruker: Company Snapshot
Table 112: Bruker: Financial Performance, FY 2022 and 2023
Table 113: Bruker: Product Portfolio
Table 114: Bruker: News/Key Developments, 2024
Table 115: Charles River Laboratories: Company Snapshot
Table 116: Charles River Laboratories: Financial Performance, FY 2022 and 2023
Table 117: Charles River Laboratories: Service Portfolio
Table 118: Danaher Corp.: Company Snapshot
Table 119: Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 120: Danaher Corp.: Product Portfolio
Table 121: Danaher Corp.: News/Key Developments, 2022
Table 122: Illumina: Company Snapshot
Table 123: Illumina: Financial Performance, FY 2022 and 2023
Table 124: Illumina: Product Portfolio
Table 125: Promega Corp.: Company Snapshot
Table 126: Promega Corp.: Product Portfolio
Table 127: Qiagen: Company Snapshot
Table 128: Qiagen: Financial Performance, FY 2022 and 2023
Table 129: Qiagen: Product Portfolio
Table 130: Qiagen: News/Key Developments, 2024
Table 131: Revvity: Company Snapshot
Table 132: Revvity: Financial Performance, FY 2022 and 2023
Table 133: Revvity: Product Portfolio
Table 134: Thermo Fisher Scientific Inc.: Company Snapshot
Table 135: Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 136: Thermo Fisher Scientific Inc.: Product Portfolio
Table 137: Thermo Fisher Scientific Inc.: News/Key Developments, 2024
List of Figures
Summary Figure: Global Market for Drug Discovery Technologies, by Technology, 2021-2029
Figure 1: Snapshot of the Market Dynamics for Drug Discovery Technologies
Figure 2: Most Frequent Cancer Types in Women, 2022
Figure 3: Most Frequent Cancer Types in Men, 2022
Figure 4: Share of Population Aged 65 and Older in G7 Countries, 2021
Figure 5: Regional Shares of Population Aged 65+, 2016 and 2050
Figure 6: Total Stem Cell Research Funding by the NIH, 2013-2024
Figure 7: Process of Drug Discovery
Figure 8: Global Market Shares of Drug Discovery Technologies, by Technology, 2023
Figure 9: Global Market for HTS in Drug Discovery, by Region, 2021-2029
Figure 10: Global Market for Bioanalytical Instruments in Drug Discovery, by Region, 2021-2029
Figure 11: Global Market Shares of Genomics in Drug Discovery, by Region, 2023
Figure 12: Global Market Shares of Proteomics in Drug Discovery, by Region, 2023
Figure 13: Global Market Shares of Cell-based Assays and Reagents in Drug Discovery, by Region, 2023
Figure 14: Global Market Shares of Bioinformatics in Drug Discovery, by Region, 2023
Figure 15: Global Market Shares of Other Technologies in Drug Discovery, by Region, 2023
Figure 16: Global Market Shares of Drug Discovery Technologies, by Application, 2023
Figure 17: Global Market Shares of Drug Discovery Technologies in Oncology, by Region, 2023
Figure 18: Global Market Shares of Drug Discovery Technologies in Cardiology, by Region, 2023
Figure 19: Global Market Shares of Drug Discovery Technologies in Neurodegenerative Diseases, by Region, 2023
Figure 20: Global Market Shares of Drug Discovery Technologies in Immunological Diseases, by Region, 2023
Figure 21: Global Market Shares of Drug Discovery Technologies in Other Diseases, by Region, 2023
Figure 22: Global Market Shares of Drug Discovery Technologies, by End User, 2023
Figure 23: Global Market Shares of Drug Discovery Technologies in Biopharma Companies, by Region, 2023
Figure 24: Global Market Shares of Drug Discovery Technologies in Research and Academia, by Region, 2023
Figure 25: Global Market Shares of Drug Discovery Technologies in CROs, by Region, 2023
Figure 26: Global Market for Drug Discovery Technologies, by Region, 2021-2029
Figure 27: North American Market for Drug Discovery Technologies, by Product Type, 2021-2029
Figure 28: North American Market for Drug Discovery Technologies, by Application, 2021-2029
Figure 29: North American Market for Drug Discovery Technologies, by End User, 2021-2029
Figure 30: North American Market Shares of Drug Discovery Technologies, by Country, 2023
Figure 31: U.S. Market for Drug Discovery Technologies, by Technology, 2021-2029
Figure 32: U.S. Market for Drug Discovery Technologies, by Application, 2021-2029
Figure 33: U.S. Market for Drug Discovery Technologies, by End User, 2021-2029
Figure 34: Canadian Market for Drug Discovery Technologies, by Technology, 2021-2029
Figure 35: Canadian Market for Drug Discovery Technologies, by Application, 2021-2029
Figure 36: Canadian Market for Drug Discovery Technologies, by End User, 2021-2029
Figure 37: Mexican Market for Drug Discovery Technologies, by Technology, 2021-2029
Figure 38: Mexican Market for Drug Discovery Technologies, by Application, 2021-2029
Figure 39: Mexican Market for Drug Discovery Technologies, by End User, 2021-2029
Figure 40: European Market for Drug Discovery Technologies, by Technology, 2021-2029
Figure 41: European Market for Drug Discovery Technologies, by Application, 2021-2029
Figure 42: European Market for Drug Discovery Technologies, by End User, 2021-2029
Figure 43: European Market Shares of Drug Discovery Technologies, by Country, 2023
Figure 44: German Market for Drug Discovery Technologies, by Technology, 2021-2029
Figure 45: German Market for Drug Discovery Technologies, by Application, 2021-2029
Figure 46: German Market for Drug Discovery Technologies, by End User, 2021-2029
Figure 47: U.K. Market for Drug Discovery Technologies, by Technology, 2021-2029
Figure 48: U.K. Market for Drug Discovery Technologies, by Application, 2021-2029
Figure 49: U.K. Market for Drug Discovery Technologies, by End User, 2021-2029
Figure 50: French Market for Drug Discovery Technologies, by Technology, 2021-2029
Figure 51: French Market for Drug Discovery Technologies, by Application, 2021-2029
Figure 52: French Market for Drug Discovery Technologies, by End User, 2021-2029
Figure 53: Italian Market for Drug Discovery Technologies, by Technology, 2021-2029
Figure 54: Italian Market for Drug Discovery Technologies, by Application, 2021-2029
Figure 55: Italian Market for Drug Discovery Technologies, by End User, 2021-2029
Figure 56: Spanish Market for Drug Discovery Technologies, by Technology, 2021-2029
Figure 57: Spanish Market for Drug Discovery Technologies, by Application, 2021-2029
Figure 58: Spanish Market for Drug Discovery Technologies, by End User, 2021-2029
Figure 59: Rest of Europe Market for Drug Discovery Technologies, by Technology, 2021-2029
Figure 60: Rest of Europe Market for Drug Discovery Technologies, by Application, 2021-2029
Figure 61: Rest of Europe Market for Drug Discovery Technologies, by End User, 2021-2029
Figure 62: Asia-Pacific Market for Drug Discovery Technologies, by Technology, 2021-2029
Figure 63: Asia-Pacific Market for Drug Discovery Technologies, by Application, 2021-2029
Figure 64: Asia-Pacific Market for Drug Discovery Technologies, by End User, 2021-2029
Figure 65: Asia-Pacific Market Shares of Drug Discovery Technologies, by Country, 2023
Figure 66: Chinese Market for Drug Discovery Technologies, by Technology, 2021-2029
Figure 67: Chinese Market for Drug Discovery Technologies, by Application, 2021-2029
Figure 68: Chinese Market for Drug Discovery Technologies, by End User, 2021-2029
Figure 69: Japanese Market for Drug Discovery Technologies, by Technology, 2021-2029
Figure 70: Japanese Market for Drug Discovery Technologies, by Application, 2021-2029
Figure 71: Japanese Market for Drug Discovery Technologies, by End User, 2021-2029
Figure 72: Indian Market for Drug Discovery Technologies, by Technology, 2021-2029
Figure 73: Indian Market for Drug Discovery Technologies, by Application, 2021-2029
Figure 74: Indian Market for Drug Discovery Technologies, by End User, 2021-2029
Figure 75: South Korean Market for Drug Discovery Technologies, by Technology, 2021-2029
Figure 76: South Korean Market for Drug Discovery Technologies, by Application, 2021-2029
Figure 77: South Korean Market for Drug Discovery Technologies, by End User, 2021-2029
Figure 78: Australian Market for Drug Discovery Technologies, by Technology, 2021-2029
Figure 79: Australian Market for Drug Discovery Technologies, by Application, 2021-2029
Figure 80: Australian Market for Drug Discovery Technologies, by End User, 2021-2029
Figure 81: Rest of Asia-Pacific Market for Drug Discovery Technologies, by Technology, 2021-2029
Figure 82: Rest of Asia-Pacific Market for Drug Discovery Technologies, by Application, 2021-2029
Figure 83: Rest of Asia-Pacific Market for Drug Discovery Technologies, by End User, 2021-2029
Figure 84: RoW Market for Drug Discovery Technologies, by Technology, 2021-2029
Figure 85: RoW Market for Drug Discovery Technologies, by Application, 2021-2029
Figure 86: RoW Market for Drug Discovery Technologies, by End User, 2021-2029
Figure 87: RoW Market Shares of Drug Discovery Technologies, by Sub-Region, 2023
Figure 88: South American Market for Drug Discovery Technologies, by Technology, 2021-2029
Figure 89: South American Market for Drug Discovery Technologies, by Application, 2021-2029
Figure 90: South American Market for Drug Discovery Technologies, by End User, 2021-2029
Figure 91: MEA Market for Drug Discovery Technologies, by Technology, 2021-2029
Figure 92: MEA Market for Drug Discovery Technologies, by Application, 2021-2029
Figure 93: MEA Market for Drug Discovery Technologies, by End User, 2021-2029
Figure 94: Global Market Shares of Drug Discovery Technologies, by Company, 2023
Figure 95: SWOT Analysis of the Drug Discovery Technologies Market
Figure 96: Pillars of ESG
Figure 97: Benefits of ESG for Companies
Figure 98: Global ESG-Adoption Level Across All Industries, 2021 and 2022
Figure 99: Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
Figure 100: Agilent Technologies Inc.: Revenue Share, by Region, FY 2023
Figure 101: Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023
Figure 102: Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023
Figure 103: Bruker: Revenue Share, by Business Unit, FY 2023
Figure 104: Bruker: Revenue Share, by Country/Region, FY 2023
Figure 105: Charles River Laboratories: Revenue Share, by Business Unit, FY 2023
Figure 106: Charles River Laboratories: Revenue Share, by Country/Region, FY 2023
Figure 107: Danaher Corp.: Revenue Share, by Business Unit, FY 2023
Figure 108: Danaher Corp.: Revenue Share, by Country/Region, FY 2023
Figure 109: Illumina: Revenue Share, by Business Unit, FY 2023
Figure 110: Illumina: Revenue Share, by Country/Region, FY 2023
Figure 111: Qiagen: Market Share, by Business Unit, FY 2023
Figure 112: Qiagen: Revenue Share, by Region, FY 2023
Figure 113: Revvity: Revenue Share, by Business Unit, FY 2023
Figure 114: Revvity: Revenue Share, by Region, FY 2023
Figure 115: Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
Figure 116: Thermo Fisher Scientific Inc.: Revenue Share, by Region, FY 2023
